Digestive and Liver Disease

Article	Citations
Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO	78
Suppression of high-fat diet-induced obesity-associated liver mitochondrial dysfunction by docosahexaenoic acid and hydroxytyrosol co-administration	75
Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis	66
Diagnosing chronic atrophic gastritis by gastroscopy using artificial intelligence	66
Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial	65
Systemic inflammation as fuel for acute liver injury in COVID-19	61
COVID 19 and liver: An A–Z literature review	61
Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis	57
From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies	56
COVID-19 pandemic perception in adults with celiac disease: an impulse to implement the use of telemedicine	54
Assessing the impact of COVID-19 on the management of patients with liver diseases: A national survey by the Italian association for the study of the Liver	51
Impact of the COVID-19 pandemic on Gastroenterology Divisions in Italy: A national survey	48
Antidiabetic drugs and non-alcoholic fatty liver disease: A systematic review, meta-analysis and evidence map	47
Foreign body and caustic ingestions in children: A clinical practice guideline	46
Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD	45
Clinical characteristics of coronavirus disease (COVID-19) patients with gastrointestinal symptoms: A report of 164 cases	44
Quality of life in patients with moderate to severe ulcerative colitis and the impact of treatment: A narrative review	43
Intestinal ischemia in the COVID-19 era	42
Impact of COVID-19 outbreak on clinical practice and training of young gastroenterologists: A European survey	40
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging	40
COVID-19 and intestinal inflammation: Role of fecal calprotectin	39
Optimizing systemic therapy for advanced hepatocellular carcinoma: the key role of liver function	37
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part II: Treatment	36
The gut–brain axis in irritable bowel syndrome and inflammatory bowel disease	36
Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population	36

Furin inhibits epithelial cell injury and alleviates experimental colitis by activating the Nrf2-Gpx4 signaling pathway	35
COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)	33
COVID-19 in patients with inflammatory bowel disease: A systematic review of clinical data	33
Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection	32
Gastritis: The clinico-pathological spectrum	31
Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis	31
Analysis of patients attitude to undergo urgent endoscopic procedures during COVID-19 outbreak in Italy	29
A SIGE-SINGEM-AIGO technical review on the clinical use of esophageal reflux monitoring	27
Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: A systematic review and meta-analysis	27
COVID-19 in IBD: The experience of a single tertiary IBD center	27
Diagnostic delay and misdiagnosis in eosinophilic oesophagitis	27
Changes in digestive cancer diagnosis during the SARS-CoV-2 pandemic in Italy: A nationwide survey	27
Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19	27
Endoscopic ultrasound-guided gastro-enteric anastomosis: A systematic review and meta-analysis	27
Long non-coding RNA OIP5-AS1 promotes the growth of gastric cancer through the miR-367-3p/HMGA2 axis	26
Statin use improves survival in patients with pancreatic ductal adenocarcinoma: A meta-analysis	26
Update on gastroenteropancreatic neuroendocrine tumors	26
Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF)	25
Endoscopic ultrasound-guided vs ERCP-guided biliary drainage for malignant biliary obstruction: A up-to-date meta-analysis and systematic review	25
Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED)	25
Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila	23
The impact of reader fatigue on the accuracy of capsule endoscopy interpretation	23
Latest insights into the hot question of proton pump inhibitor safety – a narrative review	23
Circ-SMARCA5 suppresses colorectal cancer progression via downregulating miR-39-3p and upregulating ARID4B	22
Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population	22
Splanchnic vein thrombosis in COVID-19: A review of literature	22
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology	21
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients	21
A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial	20
Milestones to reach Hepatitis C Virus (HCV) elimination in Italy: From free-of-charge screening to regional roadmaps for an HCV-free nation	20
Seronegative autoimmune atrophic gastritis is more common in elderly patients	20
The low FODMAP diet for IBS; A multicentre UK study assessing long term follow up	20
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey	20
High rate of re-bleeding after application of Hemospray for upper and lower gastrointestinal bleeds	20
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population	20
Hepatitis C virus infection in jail: Difficult-to-reach, not to-treat. Results of a point-of-care screening and treatment program	20
Systematic Review: esophageal motility patterns in patients with eosinophilic esophagitis	19
Extraintestinal manifestation of inflammatory bowel disease in Asian patients: A multinational study	19
MAFLD vs NAFLD: Where are we?	19
Covid-19 and alcohol associated liver disease	19
Italian guidelines for the management of irritable bowel syndrome	19
Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs	18
Endoscopy during the Covid-19 outbreak: experience and recommendations from a single center in a high-incidence scenario	18
IGFBP2 upregulates ZEB1 expression and promotes hepatocellular carcinoma progression through NF-κB signaling pathway	18
Acute kidney injury is associated with increased levels of circulating microvesicles in patients with decompensated cirrhosis	18
Returning to digestive endoscopy normality will be slow and must include novelty and telemedicine	18
“Decision for adjuvant treatment in stage II colon cancer based on circulating tumor DNA:The CIRCULATE-PRODIGE 70 trial”	18
Trust in telemedicine from IBD outpatients during the COVID-19 pandemic	18
Diagnostic Approach to Acute Liver Failure in Children: A Position Paper by the SIGENP Liver Disease Working Group	18
A negative fallout of COVID-19 lockdown in Italy: Life-threatening delay in the diagnosis of celiac disease	18

Intercellular crosstalk of liver sinusoidal endothelial cells in liver fibrosis, cirrhosis and hepatocellular carcinoma	18
Leptin induces NAFLD progression through infiltrated CD8+ T lymphocytes mediating pyroptotic-like cell death of hepatocytes and macrophages	17
Prevalence and detection rate of celiac disease in Italy: Results of a SIGENP multicenter screening in school-age children	17
Vaccinations and inflammatory bowel disease – a systematic review	17
Endoscopic surveillance at 3 years after diagnosis, according to European guidelines, seems safe in patients with atrophic gastritis in a low-risk region	17
Red blood cell distribution width: A promising index for evaluating the severity and long-term prognosis of hepatitis B virus–related diseases	17
Time course and risk factors of evolution from potential to overt autoimmune gastritis	17
Efficacy and safety of albumin infusion for overt hepatic encephalopathy: A systematic review and meta-analysis	17
Difficult biliary cannulation in patients with distal malignant biliary obstruction: An underestimated problem?	16
Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group	16
Management of type-I gastric neuroendocrine neoplasms: A 10-years prospective single centre study	16
Long term results of liver transplantation for alpha-1 antitrypsin deficiency	16
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study	16
Ultrasound-guided stellate ganglion block alleviates stress responses and promotes recovery of gastrointestinal function in patients	16
Efficacy and Safety of IV albumin for non-spontaneous bacterial peritonitis infection among patients with cirrhosis: A systematic review and meta-analysis	16
Clinical guidelines for the management of inflammatory bowel disease: Update of a French national consensus	16
NAFLD, MAFLD and DAFLD	16
Treatment guidelines of metastatic colorectal cancer in older patients from the French Society of Geriatric Oncology (SoFOG)	16
Treatment of primary sclerosing cholangitis	16
Acute splanchnic vein thrombosis in patients with COVID-19: A systematic review	16
Guidelines of the Italian societies of gastroenterology on the diagnosis and management of coeliac disease and dermatitis herpetiformis	16
Female reproductive health and inflammatory bowel disease: A practice-based review	16
Differential diagnosis of pancreatic cysts: A prospective study on the role of intra-cystic glucose concentration	16
Patients with COVID-19 present with low plasma citrulline concentrations that associate with systemic inflammation and gastrointestinal symptoms	16
LncRNA miR503HG inhibits epithelial-mesenchymal transition and angiogenesis in hepatocellular carcinoma by enhancing PDCD4 via regulation of miR-15b	16
Painless chronic pancreatitis	16
Esophageal reflux hypersensitivity: Non-GERD or still GERD?	16
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease	15
Liver involvement in Gaucher disease: A practical review for the hepatologist and the gastroenterologist	15
A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis	15
Clinical management and patient outcomes of acute lower gastrointestinal bleeding. A multicenter, prospective, cohort study	15
1L- vs. 4L-Polyethylene glycol for bowel preparation before colonoscopy among inpatients: A propensity score-matching analysis	15
Onset of ulcerative colitis during SARS-CoV-2 infection	15
Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis	15
Redesign of a GI endoscopy unit during the COVID-19 emergency: A practical model	15
PD-L1 and HER2 expression in gastric adenocarcinoma and their prognostic significance	15
Intelligent detection endoscopic assistant: An artificial intelligence-based system for monitoring blind spots during esophagogastroduodenoscopy in real-time	15
Diagnostic approach to neonatal and infantile cholestasis: A position paper by the SIGENP liver disease working group	14
Clinical application of carbon nanoparticles in lymphatic mapping during colorectal cancer surgeries: A systematic review and meta-analysis	14
Management of patients with complex perianal fistulas in Crohn's disease: Optimal patient flow in the Italian clinical reality	14
Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis: Comparison of cases with and without autoimmune pancreatitis in a large cohort	14
Ustekinumab in bio-naïve and bio-failure Crohn's disease patients: Results from a « real-life » monocentric cohort.	14
Hepatitis B reactivation and immune check point inhibitors	14
Increased risk of acute liver failure by pain killer drugs in NAFLD: Focus on nuclear receptors and their coactivators	14
The application of artificial intelligence in hepatology: A systematic review	14
TRPM7 is overexpressed in human IBD-related and sporadic colorectal cancer and correlates with tumor grade	14
Current treatment options of refractory ascites in liver cirrhosis – A systematic review and meta-analysis	14
Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group	14
Predictors and outcome of emergent Liver transplantation for patients with acute-on-chronic liver failure	14
Assessment of biopsy proven liver fibrosis by two-dimensional shear wave elastography in patients with primary biliary cholangitis	14
A deep learning method to assist with chronic atrophic gastritis diagnosis using white light images	14
Genetic and non-genetic risk factors for early-onset pancreatic cancer	14
Serum bile acids in cystic fibrosis patients – glycodeoxycholic acid as a potential marker of liver disease	13
FAPI PET/CT research progress in digestive system tumours	13
TGM3 promotes epithelial–mesenchymal transition and hepatocellular carcinogenesis and predicts poor prognosis for patients after curative resection	13
The importance of sarcopenia as a prognostic predictor of the clinical course in acute severe ulcerative colitis patients	13
The outcome of Crohn's disease patients refractory to anti-TNF and either vedolizumab or ustekinumab	13
Short-term effectiveness and safety of tofacitinib in ulcerative colitis - real world data from tertiary medical centers in Israel	13
COVID-19-related thrombotic microangiopathy in a cirrhotic patient	13
Mitochondrial DNA from hepatocytes induces upregulation of interleukin-33 expression of macrophages in nonalcoholic steatohepatitis	13
Will the COVID-19 pandemic affect HCV disease burden?	13
Italian association for the study of the liver position statement on SARS-CoV2 vaccination	13
Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis	13
Liver fibrosis improvement in chronic hepatitis C after direct acting-antivirals is accompanied by reduced profibrogenic biomarkers–a role for MMP-9/TIMP-1	13
Effectiveness and safety of NER1006 versus standard bowel preparations: A meta-analysis of randomized phase-3 clinical trials	13
Two decades of pediatric celiac disease in a tertiary referral center: What has changed?	13
Genetic predisposition, lifestyle risk, and obesity associate with the progression of nonalcoholic fatty liver disease	13
Sustainability in gastroenterology and digestive endoscopy: Position Paper from the Italian Association of Hospital Gastroenterologists and Digestive Endoscopists (AIGO)	13
Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registry	13
Tumor-derived extracellular vesicles containing long noncoding RNA PART1 exert oncogenic effect in hepatocellular carcinoma by polarizing macrophages into M2	13
High ulcerative colitis and Crohn's disease ratio in a population-based registry from Córdoba, Argentina	12
SARS-CoV-2 and gastrointestinal tract: The dark side of the pandemic	12
Immunotherapy in MSI/dMMR tumors in the perioperative setting: The IMHOTEP trial	12
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines	12
Variation of faecal calprotectin level within the first three months after bowel resection is predictive of endoscopic postoperative recurrence in Crohn's disease	12
Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis: A prospective single center study	12
Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease	12
Comparison of 18FDG-PET/CT and conventional follow-up methods in colorectal cancer: A randomised prospective study	12
Transjugular intrahepatic porto-systemic shunt in cirrhotic patients with hepatorenal syndrome - chronic kidney disease: Impact on renal function	12
Faecal bile acids and colonic bile acid membrane receptor correlate with symptom severity of diarrhoea-predominant irritable bowel syndrome: A pilot study	12

Hepatic epithelioid hemangioendothelioma: An international multicenter study	12
ABCB4 variants in adult patients with cholestatic disease are frequent and underdiagnosed	12
Exosomal microRNA-25 released from cancer cells targets SIK1 to promote hepatocellular carcinoma tumorigenesis	12
Vaccinations in patients with inflammatory bowel disease	12
Avelumab versus standard second line treatment chemotherapy in metastatic colorectal cancer patients with microsatellite instability: The SAMCO-PRODIGE 54 randomised phase II trial	12
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study	12
Fecal calprotectin levels in COVID-19: Lessons from a systematic review on its use in inflammatory bowel disease during the pandemic	11
Post COVID-19 cholangiopathy – A deep dive	11
Uncontrolled diabetes mellitus increases risk of infection in patients with advanced cirrhosis	11
A retrospective study on efficacy of the ERAS protocol in patients undergoing surgery for Crohn disease: A propensity score analysis	11
Clinical and gastro-duodenal histopathological features of enteropathy due to angiotensin II receptor blockers	11
Inflammatory bowel diseases and the risk of adverse health outcomes: Umbrella review of meta-analyses of observational studies	11
Screening for active COVID-19 infection and immunization status prior to biologic therapy in IBD patients at the time of the pandemic outbreak	11
Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study	11
Preprocedural prophylaxis with blood products in patients with cirrhosis: Results from a survey of the Italian Association for the Study of the Liver (AISF)	11
B-cell activating factor (BAFF) expression is associated with Crohn's disease and can serve as a potential prognostic indicator of disease response to Infliximab treatment	11
Effect of poorly absorbable antibiotics on hepatic venous pressure gradient in cirrhosis: A systematic review and meta-analysis	11
Appendiceal tumors and pseudomyxoma peritonei: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (RENAPE, RENAPATH, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFR	11
ADAMTS-13/von Willebrand factor ratio: A prognostic biomarker for portal vein thrombosis in compensated cirrhosis. A prospective observational study	11
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors	11
Higher rate of en bloc resection with underwater than conventional endoscopic mucosal resection: A meta-analysis	11
Low frequency of COVID-19 in inflammatory bowel diseases	11
Early rebleeding increases mortality of variecal bleeders on secondary prophylaxis with β-blockers and ligation	11
Spontaneous portosystemic shunts in cirrhosis: Detection, implications, and clinical associations	11
Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients undergoing anti-TNFα therapy	11
Systematic review and meta-analysis: Artificial intelligence for the diagnosis of gastric precancerous lesions and Helicobacter pylori infection	11
Clinical impact of videocapsule and double balloon enteroscopy on small bowel bleeding: Results from a large monocentric cohort in the last 19 years	11
Gastric microbiota composition in patients with corpus atrophic gastritis	10
Systemic steroids have a role in treating esophageal strictures in pediatric eosinophilic esophagitis	10
Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation	10
Kidney function monitoring in inflammatory bowel disease: The MONITORED consensus	10
Assessment of public perceptions and concerns of celiac disease: A Twitter-based sentiment analysis study	10
Long non-coding RNA HAND2-AS1 inhibits gastric cancer progression by suppressing TCEAL7 expression via targeting miR-769–5p	10
Exposed endoscopic full-thickness resection without laparoscopic assistance for gastric submucosal tumors: A systematic review and pooled analysis	10
Portal Hypertension and Ascites: Patient-and Population-centered Clinical Practice Guidelines by the Italian Association for the Study of the Liver (AISF)	10
MRI features for differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A systematic review and meta-analysis	10
Risk factors for hepatic encephalopathy and mortality in cirrhosis: The role of cognitive impairment, muscle alterations and shunts	10
Relationship between duodenal microbiota composition, clinical features at diagnosis, and persistent symptoms in adult Coeliac disease	10
Early microscopic findings in preclinical inflammatory bowel disease	10
Endoscopic snare papillectomy for adenoma of the ampulla of vater: Long-term results in 135 consecutive patients	10
The Baveno VII concept of cirrhosis recompensation	10
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian S	10
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank	10
Proportional incidence of interval colorectal cancer in a large population-based faecal immunochemical test screening programme	10
Histological assessment of gastric pseudopyloric metaplasia: Intra- and inter-observer consistency	10
Magnetic resonance imaging assessment of body composition parameters in Crohn's disease	10
WTAP-mediated m6A modification on circCMTM3 inhibits hepatocellular carcinoma ferroptosis by recruiting IGF2BP1 to increase PARK7 stability	10
Trends in cirrhosis hospitalizations during the COVID-19 pandemic	10
A systematic review and meta-analysis on the impact of pre-existing and new-onset atrial fibrillation on outcomes before and after liver transplantation	10
HBx acts as an oncogene and promotes the invasion and metastasis of hepatocellular carcinoma both in vivo and vitro	10
Medical therapy versus surgery in moderate-to-severe ulcerative colitis	10
Clinical features and psychological impact of celiac disease at diagnosis	10
FOLFIRINEC: a randomized phase II trial of mFOLFIRINOX vs platinum-etoposide for metastatic neuroendocrine carcinoma of gastroenteropancreatic or unknown origin	9
Treatment Trends for Eosinophilic Esophagitis and the Other Eosinophilic Gastrointestinal Diseases: Systematic Review of Clinical Trials	9
The faecal scent of inflammatory bowel disease: Detection and monitoring based on volatile organic compound analysis	9
HOTAIR modulates hepatocellular carcinoma progression by activating FUT8/core-fucosylated Hsp90/MUC1/STAT3 feedback loop via JAK1/STAT3 cascade	9
Effects of anti–TNF-alpha therapy on hemoglobin levels and anemia in patients with inflammatory bowel disease	9
Ferric carboxymaltose treatment for iron deficiency anemia in children with inflammatory bowel disease: Efficacy and risk of hypophosphatemia	9
Collagenous gastritis: Epidemiology and clinical associations	9
Eosinophilic gastrointestinal disorders in children and adolescents: A single-center experience	9
Therapeutic adherence recorded in the outpatient follow-up of inflammatory bowel diseases in a referral center: Damages of COVID-19	9
The safety and efficacy evaluation of sodium-glucose co-transporter 2 inhibitors for patients with non-alcoholic fatty liver disease: An updated meta-analysis	9
The global, regional, and national burden of inflammatory bowel diseases, 1990–2019: A systematic analysis for the global burden of disease study 2019	9
The diagnostic value of exosomal miRNAs in human bile of malignant biliary obstructions	9
Splenic-hepatic elastography index is useful in differentiating between porto-sinusoidal vascular disease and cirrhosis in patients with portal hypertension	9
Long non-coding RNA CASC9 promotes the progression and development of gastric cancer via regulating miR-370/EGFR axis	9
What gastroenterologists should know about direct oral anticoagulants	9
c-Myc affects hedgehog pathway via KCNQ1OT1/RAC1: A new mechanism for regulating HSC proliferation and epithelial-mesenchymal transition	9
The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices	9
Kidney function monitoring to prevent 5-aminosalicylic acid nephrotoxicity: What the gastroenterologist should know	9
Systematic assessment of environmental factors for gastroesophageal reflux disease: An umbrella review of systematic reviews and meta-analyses	9
Laryngeal signs and pH-multichannel intraluminal impedance in infants and children: The missing ring	9
Epidemiological trends of pediatric IBD in Italy: A 10-year analysis of the Italian society of pediatric gastroenterology, hepatology and nutrition registry	9
Italian registry of families at risk of pancreatic cancer: AISP Familial Pancreatic Cancer Study Group	9
IBDs and the pediatric age: Their peculiarities and the involvement of the microbiota	9
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis	9
PRODIGE 59-DURIGAST trial: A randomised phase II study evaluating FOLFIRI + Durvalumab ± Tremelimumab in second-line of patients with advanced gastric cancer	9
Colectomy rates in ulcerative colitis: A systematic review and meta-analysis	9
Complete response to the combination of sintilimab and IBI305 for a patient with HBV-associated hepatocellular carcinoma with multiple lung metastasis	9
Safety in digestive endoscopy procedures in the covid era recommendations in progres of the italian society of digestive endoscopy	9
Effectiveness of a screening program for HBV, HCV, and HIV infections in African migrants to Sicily	9
Differences between childhood- and adulthood-onset eosinophilic esophagitis: An analysis from the EoE connect registry	9
Older patients with eosinophilic esophagitis have high treatment response to topical steroids	9
Tumor cells derived-extracellular vesicles transfer miR-3129 to promote hepatocellular carcinoma metastasis by targeting TXNIP	9
Gastrointestinal endoscopy in children and adults: How do they differ?	9
Pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous tumor: Different prognostic factors for different overall survival	9
Genome-wide DNA methylation profiling in nonalcoholic fatty liver reveals predictive aberrant methylation in PRKCE and SEC14L3 promoters	9
Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease	8
LncRNA ILF3-AS1 promotes cell migration, invasion and EMT process in hepatocellular carcinoma via the miR-628–5p/MEIS2 axis to activate the Notch pathway	8
Children and Fecal SARS-CoV-2 shedding: Just the tip of the Iceberg of Italian COVID-19 outbreak?	8
Bulevirtide monotherapy at low and high dose in patients with chronic hepatitis delta: 24 weeks interim data of the phase 3 MYR301 study	8
AISF update on the diagnosis and management of adult-onset lysosomal storage diseases with hepatic involvement	8
Pseudogene PLGLA exerts anti-tumor effects on hepatocellular carcinoma through modulating miR-324–3p/GLYATL1 axis	8
Double-headed small-bowel capsule endoscopy: Real-world experience from a multi-centre British study	8
Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology	8